Medicamen Biotech Ltd. logo

Medicamen Biotech Ltd. (MEDICAMEQ)

Market Closed
7 Aug, 22:00
MSE MSE
235. 70
-3.2
-1.3395%
- Market Cap
45.23 P/E Ratio
1% Div Yield
1,085 Volume
0 Eps
238.9
Previous Close
Add Transaction
Day Range
234.75 238.9
Year Range
216 454
Want to track MEDICAMEQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MEDICAMEQ closed Friday lower at ₹235.7, a decrease of -1.3395% from Thursday's close, completing a monthly decrease of -7.5324% or -₹19.2. Over the past 12 months, MEDICAMEQ stock lost -36.3747%.
MEDICAMEQ pays dividends to its shareholders, with the most recent payment made on Oct 26, 2025. The next estimated payment will be in In 2 months on Oct 26, 2026 for a total of ₹1.
The last earnings report, released on Apr 06, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 1.193%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

MEDICAMEQ Chart

Medicamen Biotech Ltd. (MEDICAMEQ) FAQ

What is the stock price today?

The current price is ₹235.70.

On which exchange is it traded?

Medicamen Biotech Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is MEDICAMEQ.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1%.

What is its market cap?

As of today, no market cap data is available.

Has Medicamen Biotech Ltd. ever had a stock split?

No, there has never been a stock split.

Medicamen Biotech Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Rajesh Madan B. Pharma CEO
MSE Exchange
INE646B01010 ISIN
IN Country
376 Employees
19 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

Medicamen Biotech Limited is a distinguished entity in the pharmaceutical sector, entrenched in the vital process of researching, developing, manufacturing, marketing, selling, and distributing pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) across India. With its foundations laid in 1993 and headquartered in New Delhi, India, the company has evolved into a pivotal player within the pharmaceutical industry. It prides itself on a broad portfolio of products that cater to a wide range of therapeutic areas, ensuring that it plays a significant role in enhancing healthcare standards and quality of life.

Products and Services

The product offerings of Medicamen Biotech Limited are diversified and tailored to meet the dynamic needs of the healthcare sector. Their comprehensive range encompasses:

  • Tablets: Medicamen Biotech Limited specializes in the production of non-beta lactam tablets, showcasing their expertise in creating solid oral formulations that address various health conditions.
  • Capsules: The company manufactures both beta and non-beta lactam capsules, ensuring versatility and breadth in medication form, catered to different patient needs and preferences.
  • Liquid and Dry Syrups: Their portfolio also includes a variety of liquid and dry syrups, offering alternative oral dosage forms for patients who may find solid forms difficult to consume, like children and the elderly.
  • Ointments and Creams: Medicamen Biotech extends its manufacturing capabilities to topical formulations such as ointments and creams, targeting dermatological conditions and offering solutions for external use.
  • Oral Solid and Liquid Products: The company further provides a broad spectrum of oral solid and liquid products, emphasizing its commitment to catering to the comprehensive needs of the healthcare sector.

The wide array of products is meticulously designed to address various therapeutic areas, including but not limited to gastrointestinal disorders, pain management, anti-infectives, pediatrics, dermatology, gynecology, rheumatology, diabetology, cardiology, oncology, and central nervous system ailments. This diverse product range underscores Medicamen Biotech Limited’s dedication to contributing significantly to the global healthcare landscape, through the provision of quality pharmaceutical solutions.

Contact Information

Address: 1506, Chiranjiv Tower, New Delhi, India, 110019
Phone: 91 11 4758 9500